Analysis
Oura Health filed an updated S-1/A on September 21 setting terms for its Nasdaq listing under ticker OURA, according to TechCrunch and Yahoo Finance:
- Price range -- $40-$44 per share across 50 million shares offered
- Raise (max) -- up to $2.2 billion
- Fully diluted valuation -- up to $15.62 billion
- Market value on outstanding shares alone -- $14.1 billion at the top of the range
Who Actually Gets Paid
Of the 50 million shares in the offering, only 13.5 million are being sold by the company. The remaining 36.5 million -- about 73% of the total -- come from existing shareholders and employees cashing out. That split means the bulk of the up-to-$2.2 billion raised functions as a liquidity event for early backers and staff, not fresh growth capital for Oura's own operations. Public investors buying into this IPO are mostly buying out insiders, at a price set near the top of a multiyear run-up in valuation.
From A Finnish Ring To A Decacorn
Oura was founded in 2013 in Finland by Petteri Lahtela, Kari Kivelä and Markku Koskela, building a ring that tracks sleep, recovery and daily "readiness" scores. Tom Hale took over as CEO in 2022 as Lahtela stepped back from day-to-day leadership. The company has raised $1.32 billion across 13 rounds from investors including Fidelity, Square, Temasek and glucose-monitoring company Dexcom:
- Series D -- $200 million in December 2024 at a $5.2 billion valuation
- Series E -- $900 million in October 2025 at an $11 billion mark, making Oura Europe's first health-tracking decacorn
Pulse previously covered Oura's place in this fall's IPO pipeline alongside Anthropic's own reported listing plans.
The Competitive Field
IDC puts Oura's share of the global smart ring market above 80%, with more than 5.5 million devices sold and over half of those shipped in just the past year -- a dominant position ahead of Ultrahuman and Samsung's Galaxy Ring, its closest direct smart-ring rivals. The nearer financial comparable sits one category over, in wrist-worn fitness tracking:
- Whoop Series G (March 2026) -- $575 million raised at a $10.1 billion valuation, more than tripling its prior $3.6 billion mark
- Whoop 2025 financials -- $260 million in revenue against a $1.1 billion bookings run rate
Whoop CEO Will Ahmed has said that round is meant to be the company's last private raise before its own IPO. Apple Watch remains the largest wearable overall by unit volume, though it competes on a different form factor and price point than either ring-first company.
The Numbers In Context
Here's how Oura's IPO target stacks up against its own revenue and against Whoop's last private mark:
- Oura 2024 revenue -- about $500 million, projected to top $1 billion in 2025
- Oura's implied multiple -- roughly 15x, based on the $15.62 billion target against ~$1 billion in 2025 revenue
- Whoop's implied multiple -- nearly 39x, based on its $260 million 2025 revenue against its last private valuation
That gap suggests Oura is pricing this listing with more public-market discipline than the wearables category's private funding rounds have shown recently, even as its own valuation still jumped 42% in under a year.
What The Headline Misses
A richly priced IPO dominated by secondary shares leaves Oura with less fresh capital cushion than the $2.2 billion headline implies, at a moment when Samsung and Apple can fund competing hardware out of balance sheets many times Oura's size. The 73% secondary split is standard for a mature, profitable-adjacent consumer hardware company at this stage, but it means the deal's success is measured almost entirely by where OURA trades after listing, not by how the company deploys new capital -- there is comparatively little of that to deploy.
What Founders And GPs Should Watch
For consumer hardware founders, Oura's path -- 13 rounds, $1.32 billion raised, and 12 years from founding to IPO -- is a reminder of how much capital and patience a category leader needs before an exit even after reaching dominant market share. For GPs holding wearables exposure, the read-through is whether Oura's revenue multiple discipline relative to Whoop's private mark holds once public markets have a full quarter of earnings to judge it against, and whether Whoop's own promised IPO prices richer or cheaper once it has Oura's trading history to reference.
Where OURA opens against the $40-$44 range next week will say as much about appetite for the wearables category broadly as it does about Oura specifically.